Can strong chemo alone match standard care for rectal cancer?
NCT ID NCT03875781
Summary
This study is testing whether a three-month course of strong chemotherapy before surgery works as well as the current standard approach of chemotherapy followed by radiation for locally advanced rectal cancer. It will involve 540 patients across France who have rectal cancer that can be surgically removed. The main goal is to see if patients receiving only chemotherapy before surgery have similar three-year survival without cancer progression compared to those getting both treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BENOIST
RECRUITINGLe Kremlin-Bicêtre, Île-de-France Region, 94275, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.